Goodwin Procter advised Bicara Therapeutics on the offering, and Ropes & Gray advised the underwriters. Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company, announced the...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Chiesi Group on the transaction, and Latham & Watkins advised Gossamer Bio. Chiesi Group announced it has entered into a global collaboration...
You must be a Standard 1 Year member to access this content.
Latham & Watkins is advising Rhythm Pharmaceuticals on the transaction, and Ropes & Gray is advising Perceptive Advisors LLC. Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (Rhythm), a commercial-stage...
You must be a Standard 1 Year member to access this content.
